Charming Medical Limited income statement MCTA

Annual Quarterly

In fiscal 2026, which ended Mar 31, 2026, Charming Medical Limited reported revenue of $2.6 million. It recorded a net loss of $22,648. The operating loss came to $29,237, an operating margin of -1.1%. Diluted earnings per share were $0.00.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

FY 2026
Mar 31, 2026
Revenue
3
Cost of revenue
0
Gross profit
3
Operating income
-0
Other income (expense)
0
Pretax income
0
Income tax
0
Net income
-0
Basic EPS
0.00
Diluted EPS
0.00
Weighted average shares, basic
16
Weighted average shares, diluted
16
Other measures
Depreciation and amortization
0
EBITDA
0
Interest coverage
-1.85x
Margins
Gross margin
98.65%
Operating margin
-1.12%
Pretax margin
5.10%
Profit margin
-0.86%
EBITDA margin
7.14%
Effective tax rate
116.97%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MCTA (Nasdaq)
Headquarters
Hong Kong, Hong Kong
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2035992

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.